Cited by 246Cannabis and Cannabinoid ResearchStress Responses and CortisolTreatment of Major Depression

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment

Open access

Hill, Matthew N., Carrier, Erica J., McLaughlin, Ryan J., Morrish, Anna C., Meier, Sarah E., Hillard, Cecilia J., Gorzalka, Boris B.·2008·Journal of Neurochemistry

DOI 10.1111/j.1471-4159.2008.05567.xPMC PMC2606621

Open this paper in CoChat — free account

Abstract

It has been suggested that disturbances in endocannabinoid signaling contribute to the development of depressive illness; however, at present there is insufficient evidence to allow for a full understanding of this role. To further this understanding, we performed an analysis of the endocannabinoid system in an animal model of depression. Male rats exposed to chronic, unpredictable stress (CUS) for 21 days exhibited a reduction in sexual motivation, consistent with the hypothesis that CUS in rats induces depression‐like symptoms. We determined the effects of CUS, with or without concurrent treatment with the antidepressant imipramine (10 mg/kg), on CP55940 binding to the cannabinoid CB 1 receptor; whole tissue endocannabinoid content; and fatty acid amide hydrolase (FAAH) activity in the prefrontal cortex, hippocampus, hypothalamus, amygdala, midbrain and ventral striatum. Exposure to CUS resulted in a significant increase in CB 1 receptor binding site density in the prefrontal cortex and a decrease in CB 1 receptor binding site density in the hippocampus, hypothalamus and ventral striatum. Except in the hippocampus, these CUS‐induced alterations in CB 1 receptor binding site density were attenuated by concurrent antidepressant treatment. CUS alone produced a significant reduction in N‐arachidonylethanolamine (anandamide) content in every brain region examined, which was not reversed by antidepressant treatment. These data suggest that the endocannabinoid system in cortical and subcortical structures is differentially altered in an animal model of depression and that the effects of CUS on CB 1 receptor binding site density are attenuated by antidepressant treatment while those on endocannabinoid content are not.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2008.05567.x

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R)
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,616
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
Willner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605

Show all 98 references

Research works printed but not linked: 4

Hillard C. J., 2006, Regulation of cannabinoid receptor expression by chronic unpredictable stress in rats and mice, Soc. Neurosci. Abstr.
Pazos A., 2006, Constitutive activity of cannabinoid CB1 receptors in major depression, Soc. Neurosci. Abstr.
Reich C. G., 2007, Stress‐induced modulation of the endocannabinoid system in the HPA axis: effects of gonadal status, Soc. Neurosci. Abstr.
10.1002/1520-6394(2000)12:1 <2::AID-DA2>3.0.CO;2-4 · DOI

Sorted by citations

Items 101–200 of 246

Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic pain
Mlost, J., Wąsik, A., & Starowicz, K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.029 · Cited by 38
The cannabinoid receptor 1 and its role in influencing peripheral metabolism
O’Keefe, L., Simcocks, A. C., Hryciw, D. H., Mathai, M. L., & McAinch, A. J. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12144 · Cited by 38
Antidepressant-like effects of Δ9-tetrahydrocannabinol and rimonabant in the olfactory bulbectomised rat model of depression
ElBatsh, M. M., Moklas, M. A. M., Marsden, C. A., & Kendall, D. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.05.009 · Cited by 35
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB1 receptor antagonists
Kirilly, E., Hunyady, L., & Bagdy, G. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0900-1 · Cited by 34
Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain
Jiang, H., Ke, B., Liu, J., Ma, G., Hai, K., Gong, D., Yang, Z., & Zhou, C. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003563 · Cited by 35
The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs
Hassanzadeh, P., & Rahimpour, S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2120-4 · Cited by 33
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
Wang, S., Sun, H., Liu, S., Wang, T., Guan, J.-Q., & Jia, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.01.006 · Cited by 33
Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood Disorders
Rocha, L., Çınar, R., Guevara‐Guzmán, R., Alonso‐Vanegas, M., San‐Juan, D., Martínez-Juárez, I. E., Castañeda‐Cabral, J. L., & Carmona-Cruz, F. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00052 · Cited by 31
Endocannabinoid-serotonin systems interaction in health and disease
Colangeli, R., Teskey, G. C., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.003 · Cited by 31
Ginseng total saponins and Fuzi total alkaloids exert antidepressant-like effects in ovariectomized mice through BDNF-mTORC1, autophagy and peripheral metabolic pathways
Jin, Y., Pang, H., Zhao, L., Zhao, F., Cheng, Z., Liu, Q., Cui, R., Yang, W., & Li, B. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154425 · Cited by 33
Effects of Cocaine Self-Administration and Its Extinction on the Rat Brain Cannabinoid CB1 and CB2 Receptors
Bystrowska, B., Frankowska, M., Smaga, I., Pomierny-Chamioło, L., & Filip, M. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9910-6 · Cited by 31
Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats
Carnevali, L., Statello, R., Vacondio, F., Ferlenghi, F., Spadoni, G., Rivara, S., Mor, M., & Sgoifo, A. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.12.119 · Cited by 30
Depressive symptoms are negatively associated with hair N-arachidonoylethanolamine (anandamide) levels: A cross-lagged panel analysis of four annual assessment waves examining hair endocannabinoids and cortisol
Walther, A., Kirschbaum, C., Wehrli, S., Rothe, N., Penz, M. S., Wekenborg, M., & Gao, W. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110658 · Cited by 30
Changes in the cannabinoids receptors in rats following treatment with antidepressants
Smaga, I., Zaniewska, M., Gawliński, D., Faron‐Górecka, A., Szafrański, P. W., Cegla, M. T., & Filip, M. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.08.012 · Cited by 30
Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain
Ortega, J. E., González-Lira, V., Horrillo, I., Herrera‐Marschitz, M., Callado, L. F., & Meana, J. J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.043 · Cited by 29
Elevated Brain Fatty Acid Amide Hydrolase Induces Depressive-Like Phenotypes in Rodent Models: A Review
Rafiei, D., & Kolla, N. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031047 · Cited by 30
Solid lipid nanoparticles loading with curcumin and dexanabinol to treat major depressive disorder
He, X.-L., Yang, L., Wang, Z., Huang, R., Zhu, R., & Cheng, L.-M. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.293155 · Cited by 28
Sex and stressor modality influence acute stress-induced dynamic changes in corticolimbic endocannabinoid levels in adult Sprague Dawley rats
Vecchiarelli, H. A., Morena, M., Lee, T. T. ‐., Nastase, A. S., Aukema, R. J., Leitl, K. D., Gray, J. M., Petrie, G. N., Tellez-Monnery, K., & Hill, M. N. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100470 · Cited by 29
Self-citation
Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior
Schroeder, M., Eberlein, C. K., de Zwaan, M., Kornhuber, J., Bleich, S., & Frieling, H. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.025 · Cited by 26
Endocannabinoid signaling in adult hippocampal neurogenesis: A mechanistic and integrated perspective
Oddi, S., Fiorenza, M. T., & Maccarrone, M. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101239 · Cited by 27
Could a blood test for PTSD and depression be on the horizon?
Aspesi, D., & Pinna, G. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1544894 · Cited by 26
Sex differences in the interactive effects of early life stress and the endocannabinoid system
Dow-Edwards, D. L. (2020) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2020.106893 · Cited by 27
Inhibition of the fatty acid amide hydrolase changes behaviors and brain catecholamines in a sex-specific manner in rats exposed to chronic unpredictable stress
Janković, M., Spasojević, N., Ferizović, H., Stefanović, B., & Dronjak, S. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113174 · Cited by 26
What you eat is what you are – A role for polyunsaturated fatty acids in neuroinflammation induced depression?
Pascoe, M. C., Crewther, S. G., Carey, L. M., & Crewther, D. P. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.03.013 · Cited by 24
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link?
Fogaça, M. V., Galve‐Roperh, I., Guimarães, F. S., & Campos, A. C. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030003 · Cited by 24
Design and development of biomimetic quadruped robot for behavior studies of rats and mice
Ishii, H., Masuda, Y., Miyagishima, S., Fumino, S., Takanishi, A., Laschi, C., Mazzolai, B., Mattoli, V., & Dario, P. (2009) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2009.5335307 · Cited by 24
Brain region‐specific changes in N‐acylethanolamine contents with time of day
Liedhegner, E. S., Sasman, A., & Hillard, C. J. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12495 · Cited by 25
Self-citation
Long term effects of peripubertal stress on excitatory and inhibitory circuits in the prefrontal cortex of male and female mice
Bueno-Fernández, C., Pérez-Rando, M., Alcaide, J., Coviello, S., Sandi, C., Castillo-Gómez, E., & Nácher, J. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100322 · Cited by 23
Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome
Forteza, F., Giorgini, G., & Raymond, F. (2021) · Cells · doi:10.3390/cells10040938 · Cited by 23
Exo- and Endo-cannabinoids in Depressive and Suicidal Behaviors
Thippaiah, S. M., Iyengar, S. S., & Vinod, K. Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.636228 · Cited by 21
Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders
Mato, S., Pilar-Cuéllar, F., Valdizán, E. M., González‐Maeso, J., Rodríguez‐Puertas, R., Meana, J. J., Sallés, J., Crespo‐Facorro, B., & Pazos, Á. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.012 · Cited by 24
Paracetamol potentiates the antidepressant-like and anticompulsive-like effects of fluoxetine
Manna, S. S., & Umathe, S. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000104 · Cited by 21
Further evidence of anxiety- and depression-like behavior for total genetic ablation of cannabinoid receptor type 1
Soriano, D., Brusco, A., & Caltana, L. R. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113007 · Cited by 18
Serum endocannabinoids and N-acyl ethanolamines and the influence of simulated solar UVR exposure in humans in vivo
Felton, S. J., Kendall, A. C., Almaedani, A. F. M., Urquhart, P., Webb, A. R., Kift, R., Vail, A., Nicolaou, A., & Rhodes, L. E. (2017) · Photochemical & Photobiological Sciences · doi:10.1039/c6pp00337k · Cited by 20
Psychopharmacology of chronic pain
Ciaramella, A. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64012-3.00019-8 · Cited by 20
Integrating Endocannabinoid Signalling In Depression
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Kumar, R., & BUNGAU, S. G. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01774-7 · Cited by 20
Potential Utility of Cannabidiol in Stress-Related Disorders
Lookfong, N. A., Raup‐Konsavage, W. M., & Silberman, Y. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0130 · Cited by 18
Microglial morphological/inflammatory phenotypes and endocannabinoid signaling in a preclinical model of periodontitis and depression
Robledo‐Montaña, J., Díaz-García, C., Martínez, M., Ambrosio, N., Montero, E., Marín, M. J., Virto, L., Muñoz‐López, M., Herrera, D., Sanz, M., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03213-5 · Cited by 19
Pharmacological inhibition of FAAH activity in rodents: A promising pharmacological approach for psychological—cardiac comorbidity?
Carnevali, L., Rivara, S., Nalivaiko, E., Thayer, J. F., Vacondio, F., Mor, M., & Sgoifo, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.013 · Cited by 18
Maternal High-Fat Diet Modulates Cnr1 Gene Expression in Male Rat Offspring
Gawliński, D., Gawlińska, K., & Smaga, I. (2021) · Nutrients · doi:10.3390/nu13082885 · Cited by 19
Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches
Kondev, V., Winters, N. D., & Patel, S. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.007 · Cited by 21
CB-1 receptors modulate the effect of the selective serotonin reuptake inhibitor, citalopram on extracellular serotonin levels in the rat prefrontal cortex
Kleijn, J., Cremers, T. I. F. H., Hofland, C. M., & Westerink, B. H. C. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.03.004 · Cited by 17
Hemisphere-dependent endocannabinoid system activity in prefrontal cortex and hippocampus of the Flinders Sensitive Line rodent model of depression
Kirkedal, C., Elfving, B., Müller, H. K., Moreira, F. A., Bîndilă, L., Lutz, B., Wegener, G., & Liebenberg, N. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.023 · Cited by 17
Influence of the CB1 cannabinoid receptors on the activity of the monoaminergic system in the behavioural tests in mice
Poleszak, E., Wośko, S., Sławińska, K., Wyska, E., Szopa, A., Doboszewska, U., Właź, P., Właź, A., Dudka, J., Szponar, J., et al. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.05.021 · Cited by 17
Circulating endocannabinoid concentrations in grieving adults
Harfmann, E. J., McAuliffe, T. L., Larson, E. R., Claesges, S. A., Sauber, G., Hillard, C. J., & Goveas, J. S. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104801 · Cited by 17
Self-citation
The medial prefrontal cortex and the cardiac baroreflex activity: physiological and pathological implications
Lagatta, D. C., Fassini, A., Terzian, A. L. B., Corrêa, F. M. D. A., & Resstel, L. B. M. (2023) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02786-5 · Cited by 16
Metabolomic analysis of animal models of depression
Tian, L., Pu, J., Liu, Y., Gui, S., Zhong, X., Song, X., Xu, S., Zhang, H., Wang, H., Zhou, W., et al. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00574-7 · Cited by 15
Involvement of the neurotrophin and cannabinoid systems in the mechanisms of action of neurokinin receptor antagonists
Hassanzadeh, P., & Hassanzadeh, A. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.01.002 · Cited by 16
Interaction Between Glucocorticoid Receptors and FKBP5 in Regulating Neurotransmission of the Hippocampus
Zhang, S., Cheon, M., Park, H.-Y., Kim, T., & Chung, C. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.12.020 · Cited by 15
Biomarkers of stress resilience: A review
Paribello, P., Branchi, I., Viglione, A., Mancini, G. F., Morena, M., Campolongo, P., & Manchia, M. (2024) · Neuroscience Applied · doi:10.1016/j.nsa.2024.104052 · Cited by 17
Higher trait neuroticism is associated with greater fatty acid amide hydrolase binding in borderline and antisocial personality disorders
Kolla, N. J., Boileau, I., & Bagby, R. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-04789-9 · Cited by 15
Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience
Madrid-Gambín, F., Gomez‐Gómez, À., Busquets-García, A., Haro, N., Marco, S., Mason, N. L., Reckweg, J. T., Mallaroni, P., Kloft, L., van Oorsouw, K. I. M., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112845 · Cited by 17
Monoacylglycerol Lipase Protects the Presynaptic Cannabinoid 1 Receptor from Desensitization by Endocannabinoids after Persistent Inflammation
Bouchet, C. A., McPherson, K. B., Coutens, B., Janowsky, A. J., & Ingram, S. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0037-23.2023 · Cited by 15
Endocannabinoid system in the neurodevelopment of GABAergic interneurons: implications for neurological and psychiatric disorders
Song, C., Kang, X., Yang, F., Du, W., Zhang, J., Liu, L., Kang, J., Jia, N., Yue, H., Fan, L., et al. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0134 · Cited by 15
Cannabis Use and Psychiatric Disorders: Implications for Mental Health and Addiction Treatment
Halah, M. P., Zochniak, M. P., Barr, M. S., & George, T. P. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0128-5 · Cited by 13
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
Bockstaele, E. J. V. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6 · Cited by 14
Placebo Effects in a Multiple Sclerosis Spasticity Enriched Clinical Trial with the Oromucosal Cannabinoid Spray ( THC / CBD ): Dimension and Possible Causes
Marzo, V. D., & Centonze, D. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12358 · Cited by 12
The Role of the Endocannabinoids in Suppression of the Hypothalamic-pituitary-adrenal Axis Activity by Doxepin.
Hassanzadeh, P., & Hassanzadeh, A. (2011) · Europe PMC (PubMed Central) · Cited by 12
The role of endocannabinoid system and TRPV1 receptors in the antidepressant and anxiolytic effects of dipyrone in chronic unpredictable mild stress in mice
Topuz, R. D., Çetinkaya, M. Z., Erümit, D., Aydemir, K. D., Gündüz, Ö., Karadağ, Ç. H., & Ulugöl, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174315 · Cited by 12
N-oleoyl glycine and N-oleoyl alanine attenuate alcohol self-administration and preference in mice
Shahen-Zoabi, S., Smoum, R., Bingor, A., Grad, E., Nemirovski, A., Shekh‐Ahmad, T., Mechoulam, R., & Yaka, R. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02574-4 · Cited by 11
Novel discoveries in understanding the complexities of epilepsy and major depression
Dhir, A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903479688 · Cited by 11
Development of quadruped animaroid for social interaction test with rats and mice
Ishii, H., Komura, A., Masuda, Y., Miyagishima, S., Takanishi, A., Okabayashi, S., Iida, N., & Kimura, H. (2009) · IEEE/ASME International Conference on Advanced Intelligent Mechatronics · doi:10.1109/aim.2009.5229804 · Cited by 11
Stress and the ?7 Nicotinic Acetylcholine Receptor
Hunter, R. G. (2012) · Current Drug Targets · doi:10.2174/138945012800398982 · Cited by 10
Monoacylglycerol lipase alpha inhibition alters prefrontal cortex excitability and blunts the consequences of traumatic stress in rat
Worley, N. B., Varela, J. A., Gaillardetz, G. P., Hill, M. N., & Christianson, J. P. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107964 · Cited by 11
Self-citation
The Endocannabinoid System in Prefrontal Synaptopathies
Scheyer, A. F., Martin, H. G. S., & Manzoni, O. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_7 · Cited by 10
Anandamide improves food intake and orexinergic neuronal activity in the chronic sleep deprivation induction model in rats by modulating the expression of the CB1 receptor in the lateral hypothalamus
Belali, R., Mard, S. A., Khoshnam, S. E., Bavarsad, K., Sarkaki, A., & Farbood, Y. (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102336 · Cited by 9
Brain region specific regulation of anandamide (down) and sphingosine-1-phosphate (up) in association with anxiety (AEA) and resilience (S1P) in a mouse model of chronic unpredictable mild stress
Fischer, C., Thomas, D., Gurke, R., & Tegeder, I. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03012-0 · Cited by 9
Genetic variation of the 5‐HT1A rs6295, 5‐HT2A rs6311, and CNR1 rs1049353 and an altered endocannabinoid system in depressed patients
Obermanns, J., Meiser, H., Hoberg, S., Vesterager, C. S., Schulz, F., Juckel, G., & Emons, B. (2023) · Brain and Behavior · doi:10.1002/brb3.3323 · Cited by 9
Stress and Western diets increase vulnerability to neuropsychiatric disorders: A common mechanism
Dagnino‐Subiabre, A. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1661651 · Cited by 9
CB1 cannabinoid receptor ligands augment the antidepressant-like activity of biometals (magnesium and zinc) in the behavioural tests
Wośko, S., Serefko, A., Szopa, A., Właź, P., Wróbel, A., Właź, A., Górska, J., & Poleszak, E. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12880 · Cited by 8
Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder
Martin, E. L., & McRae‐Clark, A. L. (2020) · Current Addiction Reports · doi:10.1007/s40429-020-00342-8 · Cited by 8
Cannabidiol reduces the latency for the behavioral effect of escitalopram in chronically stressed male mice: involvement of NAPE-PLD expressed in parvalbumin-positive interneurons and the prefrontal cortex
Scarante, F. F., Lopes, V. D., Fusse, E. J., Vicente, M. A., de Abreu, G. H. D., Nardini, V., Sorgi, C. A., Lirio, P. H. C., Guo, F., Lu, H., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110894 · Cited by 8
The endocannabinoid system in borderline personality disorder and antisocial personality disorder: A scoping review
Ho, W., & Kolla, N. J. (2022) · Behavioral Sciences & the Law · doi:10.1002/bsl.2576 · Cited by 7
Could serum endocannabinoid and N-acylethanolamine levels be important in bipolar disorder?
Topuz, R. D., Görgülü, Y., & Uluturk, M. K. (2022) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2111713 · Cited by 6
Central and cardiac stress resilience consistently linked to integrated immuno‐neuroendocrine responses across stress models in male mice
Helman, T. J., Headrick, J. P., Peart, J. N., & Stapelberg, N. J. C. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15747 · Cited by 7
Adaptations of Striatal Endocannabinoid System During Stress
Rossi, S., Chiara, V. D., Musella, A., Mataluni, G., Sacchetti, L., Bernardi, G., Usiello, A., & Centonze, D. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8061-4 · Cited by 7
CB1 receptor signaling: Linking neuroplasticity, neuronal types, and mental health outcomes
Gao, Q., & Asim, M. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.105938 · Cited by 6
Major depressive disorder in children and adolescents is associated with reduced hair cortisol and anandamide (AEA): cross-sectional and longitudinal evidence from a large randomized clinical trial
Walther, A., Eggenberger, L., Debelak, R., Kirschbaum, C., Häberling, I. S., Osuna, E., Strumberger, M. A., Walitza, S., Baumgartner, J., Herter‐Aeberli, I., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03401-8 · Cited by 8
Circulating endocannabinoids in children and adolescents: associations with anxiety and the impact of selective serotonin reuptake inhibitors
Marusak, H. A., Zundel, C. G., Shakir, T., Ely, S. L., Carpenter, C., Shampine, M. M., Tamimi, R., Matsko, M., Rogers, S., Losiowski, J., et al. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02155-7 · Cited by 6
Self-citation
Neuronal and synaptic morphological alterations in the hippocampus of cannabinoid receptor type 1 knockout mice
Soriano, D., Vacotto, M., Brusco, A., & Caltana, L. R. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24694 · Cited by 7
Pathophysiology of Mood Disorders and Mechanisms of Action of Antidepressants and Mood Stabilizers
Fišar, Z. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_6 · Cited by 7
Fatty acid-binding protein 7 gene deletion promotes decreases in brain cannabinoid type 1 receptor binding
Lu, H., Roeder, N. M., Richardson, B., Hamilton, J., Sharma, A., Owada, Y., Kagawa, Y., & Thanos, P. K. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.138040 · Cited by 5
Alterations in plasma endocannabinoid concentrations among individuals with major depression treated with electroconvulsive therapy
Bloemhof‐Bris, E., Meiri, D., Sulimani, L., Genesh, S. N., Wexler, G., Cohen, I., Salama, A., Burshtein, I., Hirschmann, S., Feffer, K., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115967 · Cited by 7
Endocannabinoid Signaling and Synaptic Plasticity During Stress
Gray, J. M., Vecchiarelli, H. A., & Hill, M. N. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1056-4_6 · Cited by 5
Self-citation
Combinatorial approaches for treating neuropsychiatric social impairment
Don, W., Tsheringla, S., McPartland, J. C., & Allsop, S. A. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0051 · Cited by 6
Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy
Epps, S. A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1041460 · Cited by 5
Cb1 receptor-mediated signaling emerges as a novel lead to evidence-based treatment development for stress-related psychopathology
Bailey, C. R., & Neumeister, A. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.011 · Cited by 4
How depression and antidepressant drugs affect endocannabinoid system?—review of clinical and preclinical studies
Dragon, J., & Obuchowicz, E. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02938-z · Cited by 4
Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology
Laredo, S. A., Marrs, W., & Parsons, L. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_10 · Cited by 5
Depression, selective serotonin re-uptake inhibitors and the regulation of bone mass
Bab, I., & Yirmiya, R. (2009) · IBMS BoneKEy · doi:10.1138/20090357 · Cited by 3
The chronic pharmacological antagonism of the CB1 receptor is not involved in the behavioral effects of antidepressants administered in mice submitted to chronic unpredictable stress
Ribeiro, M. A., Aguiar, R. P., Scarante, F. F., Fusse, E. J., de Oliveira, R. M. W., Guimarães, F. S., & Campos, A. C. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114502 · Cited by 3
Acute stress induces different changes on the expression of CB1 receptors in the hippocampus of two lines of male rats differing in their response to stressors
Serra, M. P., Boi, M., Lai, Y., Trucas, M., Fernández‐Teruel, A., Corda, M. G., Giorgi, O., & Quartu, M. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173901 · Cited by 3
Potentiation of endocannabinoid signaling alleviates depressive-like behavior in diabetic mice
Kesharwani, A., Lahamge, D., Singh, S. K., Ravichandiran, V., & Parihar, V. K. (2025) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2025.100037 · Cited by 3
Potential Clinical Impact of Cannabidiol (CBD) in Canine and Feline Behavior: An Open-label Clinical Trial
Mogi, C., & Fukuyama, T. (2021) · Japanese Journal of Complementary and Alternative Medicine · doi:10.1625/jcam.18.37 · Cited by 3
The role of transient receptor potential vanilloid 1 (TRPV1), a modulator of the endocannabinoid system in anxiety, depression, and cocaine addiction
Norzé, W., & Maldonado-Vlaar, C. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90877-1.00029-2 · Cited by 3
Cannabinoid receptor type 1 modulates the effects of polyunsaturated fatty acids on memory of stressed rats
Peñaloza‐Sancho, V., Pérez-Valenzuela, C., Gonzalez, C., Jujihara, G., Bustos, P., & Dagnino‐Subiabre, A. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1659561 · Cited by 3
Cannabinoids, endocannabinoids and stress
Hillard, C. J., Liu, Q., Liu, X., Pan, B., Roberts, C. J., & Shi, L. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch5 · Cited by 2
Self-citation
Reward Processing in Depression
Chen, C., & Takahashi, T. (2017) · Wiley eBooks · doi:10.1002/9781119159193.ch5 · Cited by 4
Electroacupuncture alleviates chronic stress-induced anxiety via excitatory neuron CB1 receptor-dependent suppression of GR/SGK1 signaling in the mPFC
Hu, X.-F., Zhang, L.-J., Lin, Q., Ge, W., Ren, H., Zhu, S.-X., & Li, M. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121242 · Cited by 2
The Endocannabinoid System, Stress, and Mental Health
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_3 · Cited by 2

Authors: Hill, M. N., Carrier, E. J., McLaughlin, R. J., Morrish, A. C., Meier, S. E., Hillard, C. J., & Gorzalka, B. B.
Affiliations: University of British Columbia (CA)
Medical College of Wisconsin (US)
Corresponding author: Gorzalka, Boris B.
ORCID: Hill, Matthew N.
Carrier, Erica J.
McLaughlin, Ryan J.
Hillard, Cecilia J.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 2008-09
Volume: 106
Issue: 6
Pages: 2322-2336
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1111/j.1471-4159.2008.05567.x
PMC: PMC2606621
OpenAlex: W2009594014
Cited by: 246
References: 98
Citations by year: 2026: 7 · 2025: 11 · 2024: 11 · 2023: 11 · 2022: 15 · 2021: 22 · 2020: 16 · 2019: 13 · 2018: 15 · 2017: 13 · 2016: 8 · 2015: 12 · 2014: 17 · 2013: 15 · 2012: 12
FWCI: 11.21
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Journal of Neurochemistry (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Michael Smith Health Research BC
National Institutes of Health
Canadian Institutes of Health Research
Natural Sciences and Engineering Research Council of Canada
National Institute on Drug Abuse (DA 16967, R01DA016967)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords: endocannabinoid system, depression, chronic unpredictable mild stress, imipramine, antidepressant treatment, fatty acid amide hydrolase, anandamide, regional brain differences, prefrontal cortex, hippocampus, hypothalamus, amygdala, ventral striatum, sexual motivation
MeSH terms: Analgesics, Animals, Antidepressive Agents, Antidepressive Agents, Tricyclic, Arachidonic Acids, Brain, Cyclohexanols, Major Depressive Disorder, Disease Models, Animal, Imipramine, Male, Motivation, Sexual Behavior, Animal, Stress, Psychological, Rats, Long-Evans, Receptor, Cannabinoid, CB1, Rats, Polyunsaturated Alkamides, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks